ADVANCE study for Rolontis (GCSF) joke !!

I am sick and tired the way we are losing key people in the company and projecting Rolantis as a big drug. In reality Rolantis seems nothing more than a joke in comparison to Neulasta. I have to admire Nuelasta which is an amazing drug and Rolantis is no match.

Trick might work out if Gajanan Bhat and his shady chinese folks somehow cook some data and show Rolantis non-inferior than Nuelasta and FDA buys this argument.
If FDA doesn't buy it then it's gonna be a very difficult situation coz a possible FDA audit of data and monitoring will be on the cards which could mean a complete Full Stop to this chapter.

 

Who left now?

 

Spinning worthless throw-away drug like Rolontis is the only hope & HOAX left for the Indian gang.

 

Anil Hiteshi, the crooked guy who is made Regulatory head by the CEO is planning to cheat FDA on this submission. Watch out Anil carefully on each submission he makes.

 

Wow, now we understand why CEO Raj has made him VP of 5 departments including building admin and facilities.

Guess, how Admin & Facilities people will know how to file NDA submissions?? Something is terribly wrong with this company. People like them has made Drug development a joke.

 

One of the wall street analyst quoted earlier "Why would Hanmi out-license any good product in $1 mil to a shady company like SPPI while Hanmi having access to 20 biggest phrma companis including Eli-Lili, Sanofi, Pfizer, b&ei, Merck, Glaxo, Novartis, Abbvie etc.?"

Answer- Hanmi did a phase -1 trial back in 2010 which had Rolantis compound Vs Nuelasta vs Placebo and it failed misrabely. Hanmi had put this in a cold can and nobody was interested rightfully. In 2011, Raj (CEO) went to Korea and got this product out-licensed from hanmi faking it to US invstora as a blockbuster drug.

SPPI and it's crooked Asian-Indians like Pramod, Gajanan, Shiv, Anil, Raj, all know that money is actually made by fooling investors into investing into Rolantis so they can pay themseov s hug bonuses beforehand getting Rolantis NDA results. Keep an eye on these folks they will be taking huge bonyases backdoor. I heard SEC is already keeping a close eye. Stevie's blog on Bloomberg reveals all shady about SPPI. Keep reading that.

 

Very very blunt Truth. Many Ex-SPPI employee sent several written complaints to FDA over past 7 years about SPPIs functioning and Regulatory flaws. Anil Hiteshi is seen as one of the most crooked & corrupt person: that's why ODAC result for Qapzola was 14-0. FDA knows all about Anil so it seems for Rolantis every single bit of Regulatory submission will be verified back'n'forth from all sources. Rolantis to be carefully audited.

The Indian CEO of SPPI always wants to be the CEO and believes that keeping a low grade employee as his close internal SPY in the company may help protecting his seat. .......Remember, since 2001 there has been 3 attempts by board of directors to remove this CEO but he is very shrud and fires everybody who is not his spy or bootlicker. Since the, CEO chooses all board of directors instead they choosing a CEO. What a corrupt setup?

 

I agree..recently spoke to my best indian buddy in SPPI and got the truth. ROLONTIS and POZIOTINIB are failed drugs with no efficacy and bad safety profiles. SPPI got them just to make fool of local investors. These drugs are 100% bummers. Check there actual history and you will know that. You will have to dig deep for this. If you are a local investor and want to save your money then dig deep and spread the true word out to save other investors too.

 

Definitely agree about Rolontis, but thought Pozi was actually showing some good data and promise. It's what is behind the increased stock price.

 

It seems hidden Truth about POZIOTINIB lies under below link by CP-

http://www.cafepharma.com/boards/threads/data-burglars-and-manipulators-fake-results.611736/